SIU-WJU Article of the Month – June 2019
Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway
SIU Academy®. Ren S. 06/04/19; 273470
Topic: ImagingClinical applications of multiparametric MRI within the prostate cancer diagnostic pathway
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
To have an exclusive access to the entire content available on SIU Academy, become an SIU Member here.
To have an exclusive access to the entire content available on SIU Academy, become an SIU Member here.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Purpose
Multiparametric magnetic resonance imaging (mpMRI) improves clinically significant prostate cancer (csPCa)
detection by facilitating targeted biopsy (cognitive, fusion technology, or in-gantry MRI guidance) and reducing negative
biopsies. This study sought to describe the feasibility of introducing an mpMRI-based triage pathway, including diagnostic performance, applicability to training, and cost analysis.
Methods
An observational retrospective cohort study of consecutive patients attending a large public tertiary referral training
hospital who underwent mpMRI for suspicion of prostate cancer was considered. Standard clinical, MRI-related, histopathological, and financial parameters were collected for analysis of biopsy avoidance, diagnostic accuracy of biopsy approach, and operator (consultant and resident/registrar) and logistical (including financial) feasibility.
Results
653 men underwent mpMRI, of which 344 underwent prostate biopsy resulting in a 47% biopsy avoidance rate.
Overall, 240 (69.8%) patients were diagnosed with PCa, of which 208 (60.5%) were clinically significant, with higher rates of csPCa observed for higher PIRADS scores. In patients who underwent both systematic and targeted biopsy (stTPB), targeted cores detected csPCa in 12.7% and 16.6% in more men than systematic cores in PIRADS 5 and 4, respectively, whereas systematic cores detected csPCa in 5% and 3.2% of patients, where targeted cores did not. A high standard of performance was maintained across the study period and the approach was shown to be cost effective.
Conclusions
Introdution of an mpMRI-based triage system into a large public tertiary teaching hospital is feasible, cost
effective and leads to high rates of prostate cancer diagnosis while reducing unnecessary biopsies and detection of insignificant PCa.
Keywords
Prostate cancer · Multiparametric MRI · Transperineal prostate biopsy · Cognitive-fusion prostate biopsy ·
Systematic prostate biopsy · Prostate imaging reporting and data system
Multiparametric magnetic resonance imaging (mpMRI) improves clinically significant prostate cancer (csPCa)
detection by facilitating targeted biopsy (cognitive, fusion technology, or in-gantry MRI guidance) and reducing negative
biopsies. This study sought to describe the feasibility of introducing an mpMRI-based triage pathway, including diagnostic performance, applicability to training, and cost analysis.
Methods
An observational retrospective cohort study of consecutive patients attending a large public tertiary referral training
hospital who underwent mpMRI for suspicion of prostate cancer was considered. Standard clinical, MRI-related, histopathological, and financial parameters were collected for analysis of biopsy avoidance, diagnostic accuracy of biopsy approach, and operator (consultant and resident/registrar) and logistical (including financial) feasibility.
Results
653 men underwent mpMRI, of which 344 underwent prostate biopsy resulting in a 47% biopsy avoidance rate.
Overall, 240 (69.8%) patients were diagnosed with PCa, of which 208 (60.5%) were clinically significant, with higher rates of csPCa observed for higher PIRADS scores. In patients who underwent both systematic and targeted biopsy (stTPB), targeted cores detected csPCa in 12.7% and 16.6% in more men than systematic cores in PIRADS 5 and 4, respectively, whereas systematic cores detected csPCa in 5% and 3.2% of patients, where targeted cores did not. A high standard of performance was maintained across the study period and the approach was shown to be cost effective.
Conclusions
Introdution of an mpMRI-based triage system into a large public tertiary teaching hospital is feasible, cost
effective and leads to high rates of prostate cancer diagnosis while reducing unnecessary biopsies and detection of insignificant PCa.
Keywords
Prostate cancer · Multiparametric MRI · Transperineal prostate biopsy · Cognitive-fusion prostate biopsy ·
Systematic prostate biopsy · Prostate imaging reporting and data system
Purpose
Multiparametric magnetic resonance imaging (mpMRI) improves clinically significant prostate cancer (csPCa)
detection by facilitating targeted biopsy (cognitive, fusion technology, or in-gantry MRI guidance) and reducing negative
biopsies. This study sought to describe the feasibility of introducing an mpMRI-based triage pathway, including diagnostic performance, applicability to training, and cost analysis.
Methods
An observational retrospective cohort study of consecutive patients attending a large public tertiary referral training
hospital who underwent mpMRI for suspicion of prostate cancer was considered. Standard clinical, MRI-related, histopathological, and financial parameters were collected for analysis of biopsy avoidance, diagnostic accuracy of biopsy approach, and operator (consultant and resident/registrar) and logistical (including financial) feasibility.
Results
653 men underwent mpMRI, of which 344 underwent prostate biopsy resulting in a 47% biopsy avoidance rate.
Overall, 240 (69.8%) patients were diagnosed with PCa, of which 208 (60.5%) were clinically significant, with higher rates of csPCa observed for higher PIRADS scores. In patients who underwent both systematic and targeted biopsy (stTPB), targeted cores detected csPCa in 12.7% and 16.6% in more men than systematic cores in PIRADS 5 and 4, respectively, whereas systematic cores detected csPCa in 5% and 3.2% of patients, where targeted cores did not. A high standard of performance was maintained across the study period and the approach was shown to be cost effective.
Conclusions
Introdution of an mpMRI-based triage system into a large public tertiary teaching hospital is feasible, cost
effective and leads to high rates of prostate cancer diagnosis while reducing unnecessary biopsies and detection of insignificant PCa.
Keywords
Prostate cancer · Multiparametric MRI · Transperineal prostate biopsy · Cognitive-fusion prostate biopsy ·
Systematic prostate biopsy · Prostate imaging reporting and data system
Multiparametric magnetic resonance imaging (mpMRI) improves clinically significant prostate cancer (csPCa)
detection by facilitating targeted biopsy (cognitive, fusion technology, or in-gantry MRI guidance) and reducing negative
biopsies. This study sought to describe the feasibility of introducing an mpMRI-based triage pathway, including diagnostic performance, applicability to training, and cost analysis.
Methods
An observational retrospective cohort study of consecutive patients attending a large public tertiary referral training
hospital who underwent mpMRI for suspicion of prostate cancer was considered. Standard clinical, MRI-related, histopathological, and financial parameters were collected for analysis of biopsy avoidance, diagnostic accuracy of biopsy approach, and operator (consultant and resident/registrar) and logistical (including financial) feasibility.
Results
653 men underwent mpMRI, of which 344 underwent prostate biopsy resulting in a 47% biopsy avoidance rate.
Overall, 240 (69.8%) patients were diagnosed with PCa, of which 208 (60.5%) were clinically significant, with higher rates of csPCa observed for higher PIRADS scores. In patients who underwent both systematic and targeted biopsy (stTPB), targeted cores detected csPCa in 12.7% and 16.6% in more men than systematic cores in PIRADS 5 and 4, respectively, whereas systematic cores detected csPCa in 5% and 3.2% of patients, where targeted cores did not. A high standard of performance was maintained across the study period and the approach was shown to be cost effective.
Conclusions
Introdution of an mpMRI-based triage system into a large public tertiary teaching hospital is feasible, cost
effective and leads to high rates of prostate cancer diagnosis while reducing unnecessary biopsies and detection of insignificant PCa.
Keywords
Prostate cancer · Multiparametric MRI · Transperineal prostate biopsy · Cognitive-fusion prostate biopsy ·
Systematic prostate biopsy · Prostate imaging reporting and data system
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}